Plant‐Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives
Journal of Tissue Engineering and Regenerative Medicine · 2025-01 · 2025 (1)
DOI: 10.1155/term/2812191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, online erschienen am 07.01.2025. Verfasst von Jyrki Heinämäki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia. Hauptthemen laut MEDLINE: Tissue Engineering, Printing, Three-Dimensional, Bioprinting, Bone and Bones. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eesti Teadusagentuur, European Commission.
Abstract (Originalsprache)
Bone defects are becoming a true challenge in global health care due to the aging population and higher prevalence of musculoskeletal disorders. The interest in using plant‐origin compounds and plant‐derived biomaterials in bone tissue engineering (BTE) has been increased due to their availability (abundance), safety, biocompatibility, biodegradability, and low cost. Plant‐origin compounds have supportive effects on bone tissue healing, and cell‐laden plant‐derived biomaterials can be applied in formulating bioinks for three‐dimensional (3D) bioprinting to facilitate the preparation of native bone tissue–mimicking structures and customized bone scaffolds. Such plant‐derived materials also have the capacity to improve cell viability and support osteoconductive and osteoinductive properties of a bone construct. In this article, we review the ethnomedical aspects related to the use of medicinal plants and plant‐origin bioactive compounds in bone healing and the recent developments in the 3D bioprinting of bone constructs with plant‐derived biomaterials for advancing BTE. The commonly used 3D‐bioprinting techniques, the properties of plant‐origin compounds and biomaterials (for bone 3D bioprinting), and the selective examples of bone scaffolds fabricated using plant‐derived biomaterials are discussed with a special reference set on applicability, performance, advantages, limitations, and challenges. Plant‐origin compounds, biomaterials, and biomimetic 3D‐bioprinted constructs could be the basis for a next‐generation BTE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia.
- Department of Pharmacognosy, National University of Pharmacy, Kharkiv, Ukraine.
- Faculty of Pharmacy, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.
ORCID-Profile: Jyrki Heinämäki, Oleh Koshovyi, Ain Raal
Förderung
- Eesti Teadusagentuur
- European Commission
Zitieren
APA
Heinämäki, J., Koshovyi, O., Botsula, I., Shpychak, A., Vo, H. Q., Nguyen, H. T., & Raal, A. (2025). Plant‐Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives. Journal of Tissue Engineering and Regenerative Medicine, 2025(1). https://doi.org/10.1155/term/2812191
Vancouver
Heinämäki J, Koshovyi O, Botsula I, Shpychak A, Vo HQ, Nguyen HT, et al. Plant‐Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives. Journal of Tissue Engineering and Regenerative Medicine. 2025;2025(1). doi:10.1155/term/2812191
BibTeX
@article{Heinmki2025,
author = {Heinämäki, Jyrki and Koshovyi, Oleh and Botsula, Iryna and Shpychak, Alina and Vo, Hung Quoc and Nguyen, Hoai Thi and Raal, Ain},
title = {Plant‐Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/term/2812191}
}
EUVIMED